1. Practical Strategies for Getting Patients With Diabetes to Lipid Goal

2. Program Goals

3. Introduction

4. PCSK9 Inhibition: Mechanism of Action

5. Discrepancies and Commonalities Between American and European Guidelines

6. Unmet Need in Diabetes What Treatments Are Available?

7. Long-Term Efficacy and Safety Alirocumab ODYSSEY COMBO Studies

8. ODYSSEY COMBO Studies Prespecified Analysis at 52 Weeks

9. Efficacy and Safety of Alirocumab in Individual With Diabetes Analyses from ODYSSEY Combo Long-Term Study

10. Conclusions

11. Abbreviations

12. Abbreviations (cont)

13. References

14. References (cont)

15. References (cont)